rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Indaptus Therapeutics, Inc.

INDP · Nasdaq

Health CareBiotechnologyJust started moving

INDP stood above a rising 150-day average in 9 of the last 52 weekly readings, including each of the last 4 weeks. It is 15.0% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Just started moving
Weeks in an uptrend
4 in a row
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
8 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0
WhoDidSharesTraded
David E. LazarDirectorsold196,80023 Mar 2026filed 24 Mar 2026
David E. LazarDirectorsold700,00023 Mar 2026filed 24 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders8+2 on the quarter
New · exited5 · 3
Reported value$537K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202656,470$169K+29,463+109.1%
JANE STREET GROUP, LLCnew · filed 14 Aug 202653,811$161K+53,811
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 202633,652$101K+33,652
VANGUARD FIDUCIARY TRUST COnew · filed 13 Aug 202613,967$42K+13,967
MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 202611,586$35K+11,586
MORGAN STANLEYadded · filed 13 Aug 20268,936$27K+6,239+231.3%
UBS Group AGnew · filed 13 Aug 2026478$1,434+478
SBI Securities Co., Ltd.unchanged · filed 23 Jul 202617$5100.0%
31 Mar 2023 – 30 Jun 2026
51320Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

David E. Lazar Company insiderDirector · last 23 Mar 20260 · 0
Jerome D. Jabbour Company insiderDirector · last 26 Feb 20260 · 0
Jeffrey A. Meckler Company insiderCo-Chief Executive Officer · last 11 Feb 20268 · 0
Avraham Ben-Tzvi Company insiderDirector · last 20 Jan 20260 · 0
David Natan Company insiderDirector · last 7 Jan 20260 · 0
Michael James Newman Company insiderCSO and Director · last 22 Dec 20250 · 2
Nir Sassi Company insiderChief Financial Officer · last 22 Dec 20250 · 0
Walt Addison Linscott Company insiderChief Operating Officer · last 22 Dec 20251 · 0
Anthony J. Maddaluna Company insiderDirector · last 10 Jun 20250 · 0
Hila Karah Company insiderDirector · last 10 Jun 20250 · 0
Mark John Gilbert Company insiderDirector · last 10 Jun 20250 · 0
Robert Martell Company insiderDirector · last 10 Jun 20250 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 16 Mar 20263.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$8.5M

Analyst forecasts

No analyst forecasts yet.